Protect Pharmaceutical Corporation
PRTT · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -2.9% | 66.5% | 3.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 54.9% | 53.8% | 50.8% | 56.3% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 43.6% | 35% | 31.2% | 35.7% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 42.6% | 33.7% | 27.4% | 25.6% |
| EPS Diluted | 0.98 | 0.8 | 0.43 | 0.36 |
| % Growth | 22.5% | 86% | 19.4% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |